In cancer, ILC subsets may be co-opted by the tumor microenvironment to suppress antitumor immunity or promote tumor growth, with IL-17 cytokine family contributing to angiogenesis and tissue remodeling (41, 42). This evidence concerns the gene CCL27 and cancer.